Incretin and Non-Incretin Peptides

Pfizer Wins Early U.S. Antitrust Clearance for Metsera Deal as Novo’s Higher Bid Pressures Timeline

Novo Nordisk has a higher unsolicited offer deemed superior, setting a four‑day clock for Pfizer to respond.